Anti-Vascular Endothelial Growth Factor Therapy Regimens for Polypoidal Choroidal Vasculopathy: A Systematic Review

INTRODUCTION: There are no guidelines on the optimal anti-vascular endothelial growth factor (anti-VEGF) monotherapy regimen for patients with polypoidal choroidal vasculopathy (PCV). In this study, we aimed to assess the comparative safety and efficacy of different treatment regimens of anti-VEGF m...

Descripción completa

Detalles Bibliográficos
Autores principales: Mihalache, Andrew, Hatamnejad, Amin, Patil, Nikhil S., Popovic, Marko M., Muni, Rajeev H., Kertes, Peter J., Wong, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659003/
https://www.ncbi.nlm.nih.gov/pubmed/37591212
http://dx.doi.org/10.1159/000533529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659003/
https://www.ncbi.nlm.nih.gov/pubmed/37591212
http://dx.doi.org/10.1159/000533529

Ejemplares similares